Jerry Haney
Impact in
- Cancer Research top 5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Cancer Genomics and Diagnostics
- Oncology top 10%
- Colorectal Cancer Treatments and Studies
Papers in
-
- RNA modifications and cancer 4
- Angiogenesis and VEGF in Cancer 1
- Epigenetics and DNA Methylation 1
- Oncology 4
- Colorectal Cancer Treatments and Studies 2
- Co-authors
- Wilbur A. Franklin (8 shared papers)Michio Sugita (6 shared papers)Paul A. Bunn (3 shared papers)Lynne Bemis (5 shared papers)Heidi Simmons (1 shared paper)Lorelei J. Hanson (1 shared paper)York E. Miller (2 shared papers)Gilad S. Gordon (1 shared paper)
- Journals
- Journal of Clinical Oncology (2 papers)Cancer Research (2 papers)Analytical Biochemistry (1 paper)Lung Cancer (1 paper)Annals of Oncology (1 paper)
- Partner nations
- United StatesJapanBrazil
In The Last Decade
Jerry Haney
12 papers receiving 1.2k citations
Jerry Haney's Hit Papers
Peers
Comparison fields: 5 of 64
- Cancer Research 314
- Oncology 381
- Molecular Biology 726
- Pulmonary and Respiratory Medicine 234
- Pathology and Forensic Medicine 112
Countries citing papers authored by Jerry Haney
This map shows the geographic impact of Jerry Haney's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jerry Haney with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jerry Haney more than expected).
Fields of papers citing papers by Jerry Haney
This network shows the impact of papers produced by Jerry Haney. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jerry Haney. The network helps show where Jerry Haney may publish in the future.
Co-authors
The 25 scholars most cited alongside Jerry Haney, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Phase I Pharmacokinetic and Pharmacodynamic Study of the Oral, Small-Molecule Mitogen-Activated Protein Kinase Kinase 1/2 Inhibitor AZD6244 (ARRY-142886) in Patients With Advanced Cancers Hit paper breakdown → | 2008 | 476 |
| 2 | 2006 | 292 | |
| 3 | 2008 | 193 | |
| 4 | 2009 | 93 | |
| 5 | 2013 | 90 | |
| 6 | 2004 | 34 | |
| 7 | 2001 | 9 | |
| 8 | 1996 | 2 | |
| 9 | 2006 | 1 | |
| 10 | 2011 | 1 | |
| 11 | Abstract #4775: The selective aurora B kinase inhibitor AZD1152-HQPA inhibits in vitro growth of small cell lung cancer (SCLC) cell lines | 2009 | 1 |
| 12 | Comparison of Testing Methods and Tissue Sampling Techniques in Colon Cancer | 2010 | 1 |
About Jerry Haney
Jerry Haney is a scholar working on Molecular Biology, Oncology, Cancer Research, Pulmonary and Respiratory Medicine and Cell Biology, having authored 12 papers that have together received 1.2k indexed citations. Recurring topics across this work include RNA modifications and cancer (4 papers), Cancer Genomics and Diagnostics (3 papers), Lung Cancer Treatments and Mutations (2 papers), Colorectal Cancer Treatments and Studies (2 papers), Radiomics and Machine Learning in Medical Imaging (1 paper), Angiogenesis and VEGF in Cancer (1 paper), Epigenetics and DNA Methylation (1 paper) and Microtubule and mitosis dynamics (1 paper). The work is most often cited by research in Cancer Research (314 citations), Oncology (381 citations), Molecular Biology (726 citations), Pulmonary and Respiratory Medicine (234 citations) and Pathology and Forensic Medicine (112 citations). Jerry Haney has collaborated with scholars based in United States, Japan and Brazil. Frequent co-authors include Wilbur A. Franklin, Michio Sugita, Paul A. Bunn, Lynne Bemis, Heidi Simmons, Lorelei J. Hanson, York E. Miller, Gilad S. Gordon, Allison Marlow and Julian R. Molina. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research, Analytical Biochemistry, Lung Cancer and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.